Shandong Buchang Pharmaceuticals (603858.SH) announced that the company recently learned that its wholly-owned subsidiary, Yangling Buchang Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Yangling Buchang'), has obtained the Drug GMP Compliance Inspection Notification issued by the Shaanxi Provincial Drug Administration, indicating that the relevant production lines of Yangling Buchang comply with GMP requirements.
As the Shandong Buchang Pharmaceuticals (603858.SH) announcement shows, the company recently learned that its wholly-owned subsidiary Yangling Buchang Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Yangling Buchang') has obtained the Drug GMP Compliance Inspection Notification issued by the Shaanxi Provincial Drug Administration, confirming that the production lines of Yangling Buchang meet the requirements of GMP.
